Long non‐coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up‐regulation by binding to microRNA‐21
暂无分享,去创建一个
[1] R. de Cabo,et al. Maternally expressed gene 3 in metabolic programming. , 2020, Biochimica et biophysica acta. Gene regulatory mechanisms.
[2] Z. Fei,et al. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway , 2020, Anti-cancer drugs.
[3] N. Wu,et al. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR‐23a/APAF‐1 axis , 2019, Journal of cellular and molecular medicine.
[4] D. Hu,et al. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21. , 2018, European review for medical and pharmacological sciences.
[5] Cong Zhao,et al. Long noncoding RNA MEG3 inhibits proliferation and migration but induces autophagy by regulation of Sirt7 and PI3K/AKT/mTOR pathway in glioma cells , 2018, Journal of cellular biochemistry.
[6] C. Dang,et al. MEG3/miR-21 axis affects cell mobility by suppressing epithelial-mesenchymal transition in gastric cancer , 2018, Oncology reports.
[7] Yang Tan,et al. Thermal Preconditioning May Prevent Tendon Adhesion by Up-Regulating HSP72 in Rats , 2017, Cellular Physiology and Biochemistry.
[8] Zhaoming Li,et al. Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomes , 2017, Medicine.
[9] B. Liu,et al. Long non-coding RNA MEG3 induces cell apoptosis in esophageal cancer through endoplasmic reticulum stress. , 2017, Oncology reports.
[10] Z. Zong,et al. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3 , 2017, Oncotarget.
[11] S. Tsao,et al. Downregulation of long non‐coding RNA MEG3 in nasopharyngeal carcinoma , 2017, Molecular carcinogenesis.
[12] Shengjie Wu,et al. MicroRNA‐21 protects against cardiac hypoxia/reoxygenation injury by inhibiting excessive autophagy in H9c2 cells via the Akt/mTOR pathway , 2016, Journal of cellular and molecular medicine.
[13] Jian Zhang,et al. Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway. , 2016, American journal of translational research.
[14] M. Czyz,et al. Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions. , 2015, Experimental and molecular pathology.
[15] Q. Hong,et al. MiR-21 inhibits autophagy by targeting Rab11a in renal ischemia/reperfusion. , 2015, Experimental cell research.
[16] H. Ou,et al. Activation of miR-21 by STAT3 Induces Proliferation and Suppresses Apoptosis in Nasopharyngeal Carcinoma by Targeting PTEN Gene , 2014, PloS one.
[17] Guodong Yang,et al. LncRNA: a link between RNA and cancer. , 2014, Biochimica et biophysica acta.
[18] Isidore Rigoutsos,et al. MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells , 2014, RNA.
[19] Wei Chen,et al. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression. , 2014, International journal of clinical and experimental pathology.
[20] Wei Li,et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression , 2013, BMC Cancer.
[21] H. Mai,et al. Emerging treatment options for nasopharyngeal carcinoma , 2013, Drug design, development and therapy.
[22] D. Kwong,et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. , 2013, Carcinogenesis.
[23] T. Lam,et al. The battle against nasopharyngeal cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] Yunli Zhou,et al. MEG3 noncoding RNA: a tumor suppressor. , 2012, Journal of molecular endocrinology.
[25] R. Kurzrock,et al. Autophagy as a target for anticancer therapy , 2011, Nature Reviews Clinical Oncology.
[26] P. Dennis,et al. PTEN loss in the continuum of common cancers, rare syndromes and mouse models , 2011, Nature Reviews Cancer.
[27] Guanghai Yang,et al. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). , 2010, Clinica chimica acta; international journal of clinical chemistry.
[28] D. Clayton,et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes , 2009, Nature Genetics.
[29] Jianjun Chen,et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression , 2008, Laboratory Investigation.
[30] Qiong Shao,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.
[31] A. Krogh,et al. Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.
[32] B. Jiang,et al. PI3K/PTEN signaling in angiogenesis and tumorigenesis. , 2009, Advances in cancer research.